Skip to content

Biz News Today

Business News – Direct Source News

  • Home
  • Business News Videos
    • International/National News Videos
  • Directory
  • Links PRs
  • REITS
  • About
  • Contact
    • Sitemap

Nektar and Bristol Myers Squibb Announce Update on Clinical Development Program for Bempegaldesleukin (BEMPEG) in Combination with Opdivo (nivolumab)

  • Home
  • 2022
  • April
  • 14
  • Nektar and Bristol Myers Squibb Announce Update on Clinical Development Program for Bempegaldesleukin (BEMPEG) in Combination with Opdivo (nivolumab)

Original Source

On April 14, 2022

Post navigation

Previous PostDover Announces First Quarter 2022 Earnings Release Date, Conference Call and Webcast
Next PostInterpublic Schedules First Quarter 2022 Earnings Release

Related Post

May 23, 2022
  • Business News

Taiwan’s Tech Titans Adopt World’s First NVIDIA Grace CPU-Powered System Designs

May 23, 2022
  • Business News

GE Healthcare update on iodinated contrast media

May 23, 2022
  • Business News

Tyson Foods Announces Quarterly Dividend

Copyright © All right reserved
Newslist Created By Rise Themes

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/biznews/public_html/wp-includes/functions.php on line 5219